Skip to main content
. 2014 Aug 21;2014(8):CD002913. doi: 10.1002/14651858.CD002913.pub3

Summary of findings for the main comparison. Budesonide 6 mg versus placebo for maintenance of remission in Crohn's disease.

Budesonide 6 mg versus placebo for maintenance of remission in Crohn's disease
Patient or population: patients with quiescent Crohn's disease
 Settings: outpatients
 Intervention: budesonide 6 mg versus placebo
Outcomes Illustrative comparative risks* (95% CI) Relative effect
 (95% CI) No of Participants
 (studies) Quality of the evidence
 (GRADE) Comments
Assumed risk Corresponding risk
Control Budesonide 6 mg versus placebo
Continued remission at 3 months 522 per 10001 652 per 1000
 (522 to 825) RR 1.25 
 (1.00 to 1.58) 540
 (6 studies) ⊕⊕⊝⊝
 Low2,3  
Continued remission at 6 months 524 per 10001 603 per 1000
 (498 to 728) RR 1.15 
 (0.95 to 1.39) 420
 (5 studies) ⊕⊕⊕⊝
 Moderate4  
Continued remission at 12 months 476 per 10001 538 per 1000
 (447 to 643) RR 1.13 
 (0.94 to 1.35) 420
 (5 studies) ⊕⊕⊕⊝
 Moderate5  
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 CI: Confidence interval; RR: risk ratio
GRADE Working Group grades of evidence
 High quality: Further research is very unlikely to change our confidence in the estimate of effect.
 Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
 Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
 Very low quality: We are very uncertain about the estimate.

1 Control group risk estimates come from control arm of meta‐analysis, based on included trials.
 2 Unexplained heterogeneity (I2 = 56%).
 3 Sparse data (315 events).
 4 Sparse data (238 events).
 5 Sparse data (215 events).